News Phlow Corp., U.S. Pharmacopia open Richmond labs to develop new pharma techniques The Richmond area partnership that’s been working to revolutionize U.S. drug making has reached another…Super UserDecember 14, 2022
News Precigen Announces Positive Phase 1 Dose Escalation Data for Autologous PRGN-3006 UltraCAR-T® Manufactured Overnight for Next Day Infusion in Relapsed or Refractory Acute Myeloid Leukemia Patients – Single infusion of UltraCAR-T cells with or without lymphodepletion demonstrated robust expansion and persistence…Super UserDecember 14, 2022
BHI Weekly News Archives 537th Edition, December 13, 2022 Trouble Viewing This Email: Click Here December 13, 2022 FOUNDING MEMBER OF BHI’s…Super UserDecember 13, 2022
News The ‘John Holaday’ BioHealth Leadership Award: Dr. Kurt Newman, President & CEO, Children’s National Hospital In honor of the late John Holaday, Ph.D., renowned scientist, CEO, philanthropist, mentor, and community…Super UserDecember 12, 2022
News The BioBuzz Media Award: American Gene Technologies® “The Cure Chronicles” Video Series This award honors a media campaign that most aligns with our mission; ‘to create exceptional…Super UserDecember 12, 2022
News The Breakthrough Life Science Company of the Year Award: Vaccitech This award recognizes the companies who have pursued their mission with dedication and perseverance and…Super UserDecember 12, 2022
BioTalk with Rich Bendis Podcast BHI’s New BHI Executives-In-Residence Featured on BioTalk New BHI Executives-In-Residence, Jennifer Butler and Luis Gutierrez, join VP Economic Development Sarah Miller on…Super UserDecember 12, 2022
News BHI’s New BHI Executives-In-Residence Featured on BioTalk New BHI Executives-In-Residence, Jennifer Butler and Luis Gutierrez, join VP Economic Development Sarah Miller on…Super UserDecember 12, 2022
News USP Launches R&D Analytical Solutions To Advance Continuous Manufacturing Technologies USP Advanced Manufacturing Technology Lab Opens in Richmond, Virginia Rockville, MD, December 12, 2022 –…Super UserDecember 12, 2022
News Amgen Agrees to Deal to Buy Horizon Therapeutics – WSJ The U.S. biotechnology company will pay $116.50 for each Horizon share Amgen Inc. has agreed to…Super UserDecember 12, 2022